nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

08.08.2016

Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review

verfasst von: Renato Tozzoli, Danilo Villalta, Nicola Bizzaro

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Standardization and harmonization are complementary tools to achieve higher testing quality in laboratory medicine. Both are of great relevance and are strongly needed in autoimmune diagnostics, due to the impressive advance in basic research and technological development observed in this diagnostic field in recent years that has led to the introduction of many new tests and new analytical methods. It is, therefore, essential that this strong innovative thrust is translated into clinical practice in a coordinated way to avoid confusion and the risk of potentially harmful errors for the patient. However, while standardization of antibody assays is a very complex task, harmonization of procedures and behaviors is a more feasible target and should necessarily include all the phases of the total testing process—in the pre-analytical phase, appropriateness of test requests, harmonization of autoantibody terminology, and adoption of uniform nomenclature for laboratory tests; in the analytical phase, harmonization of measurements, and sharing of test profiles and diagnostic algorithms; and in the post-analytical phase, harmonization of data reporting, and criteria for interpreting immunoserological results, especially harmonization of units, reference intervals, decision limits, and definition and notification of critical values. We here provide and discuss some examples of harmonization initiatives related to anti-nuclear antibodies, TSH receptor, and anti-thyroid peroxidase antibodies and to antibodies associated with autoimmune hepatitis and with celiac disease. These initiatives could be the starting steps to achieve a wider consensus and a closer interaction among stakeholders in the path of autoimmune diagnostics harmonization to enhance clinical effectiveness and provide greater patient safety.

Miller WG, Eckfeldt JH, Passarelli J, Rosner W, Young IS (2014) Harmonization of test results: what are the challenges; how can we make it better? Clin Chem 60:923–927CrossRefPubMed

Plebani M (2015) Harmonization in laboratory medicine: requests, samples, measurements and reports. Crit Rev Clin Lab Sci 15:1–13

Tozzoli R, Bizzaro N (2012) The clinical autoimmunologist and the laboratory autoimmunologist: the two sides of the coin. Autoimmun Rev 11:766–770CrossRefPubMed

Tozzoli R, D’Aurizio F, Villalta D, Bizzaro N (2015) Automation, consolidation, and integration in autoimmune diagnostics. Autoimmun Highlights 6:1–6CrossRef

Tate JR, Johnson R, Sikaris K (2012) Harmonization in laboratory testing. Clin Biochem Rev 33:121–122PubMedPubMedCentral

Plebani M (2013) Harmonization in laboratory medicine: the complete picture. Clin Chem Lab Med 51:741–751PubMed

Legg M, Swanepoel C (2012) The Australian pathology units and terminology standardization project—an overview. Clin Biochem Rev 33:103–108PubMedPubMedCentral

Agmon-Levin N, Damoiseaux J, Kallenberg C, Sack U, Witte T, Herold M et al (2014) International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis 73:17–23CrossRefPubMed

Cinquanta L, Bizzaro N, Villalta D, Morozzi G, Tonutti E, Bagnasco M et al (2015) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Revision 2015. Riv It Med Lab [Italian] 11:205–224CrossRef

10.

Damoiseaux J, von Muhlen CA, Garcia-De La Torre I, Carballo OG, de Melo CW et al (2016) International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results. Autoimmun Highlights 7:1CrossRef

11.

Wiik AS, Høier-Madsen H, Forslid J, Charles P, Meyrowitsch J (2010) Antinuclear antibodies: a contemporary nomenclature using HEp-2 cells. J Autoimmun 35:276–290CrossRefPubMed

12.

Chan EKL, Damoiseaux J, Carballo OG et al (2015) Report of the first international consensus on standardized nomenclature of antinuclear antibody HEp-2 cell patterns 2014–2015. Front Immunol 6:412, PMID:26347739CrossRefPubMedPubMedCentral

13.

Tan EM, Feltkamp TEW, Smolen JS et al (1997) Range of antinuclear antibodies in ‘healthy’ individuals. Arthritis Rheum 40:1601–1611CrossRefPubMed

14.

Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F et al (2002) Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 117:316–324CrossRefPubMed

15.

Bizzaro N, Antico A, Platzgummer S, Tonutti E, Bassetti D, Pesente F et al (2013) Automated antinuclear immunofluorescence antibody screening: a comparative study of six computer-aided diagnostic systems. Autoimmun Rev 13:292–298CrossRefPubMed

16.

Dawkins RL, Martinez OP, Freitas EM, Hollingsworth PN (1998) Diagnosis of autoimmune disease. In: Rose NR, Mackay IR (eds) The autoimmune diseases, 3rd edn. Academic, San Diego, pp 821–831

17.

Bizzaro N, Wiik A (2004) Appropriateness in anti-nuclear antibody testing: from clinical request to strategic laboratory practice. Clin Exp Rheumatol 22:349–355PubMed

18.

Wiik AS, Bizzaro N (2012) Missing links in high quality diagnostics of inflammatory systemic rheumatic diseases. It is all about the patient! Autoimmun Highlights 3:35–49CrossRef

19.

Tonutti E, Bizzaro N, Morozzi G, Radice A, Villalta D, Cinquanta L et al (2016) The ANA-reflex test as a model for improving clinical appropriateness in autoimmune diagnostics. Autoimmun Highlights 7:9. doi: 10.1007/s13317-016-0080-3

20.

Morshed SA, Davies TF (2015) Graves’ disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies. Horm Metab Res 47:727–734CrossRefPubMedPubMedCentral

21.

Tozzoli R, Bagnasco M, Villalta D (2014) Thyrotropin receptor antibodies. In: Shoenfeld Y, Meroni PL, Gershwin ME (eds) Autoantibodies, 3rd edn. Elsevier, Amsterdam, pp 375–383CrossRef

22.

Frank CU, Braeth S, Dietrich JW, Wanjura D, Loos U (2015) Bridge technology with TSH receptor chimera for sensitive direct detection of TSH receptor antibodies causing graves’ disease: analytical and clinical evaluation. Horm Metab Res 47:880–888CrossRefPubMed

23.

Tozzoli R, D’Aurizio F, Villalta D, Giovanella L (2016) Evaluation of the first fully automated immunoassay method for the measurement of stimulating TSH receptor autoantibodies in Graves’ disease. Clin Chem Lab Med doi: 10.1515/cclm-2016-0197

24.

Tan K, Loh TP, Sethi S (2013) Lack of standardized description of TRAb assays. Endocrine 43:732–733CrossRefPubMed

25.

Czarnocka B, Cocks Eschler D, Godlewska M, Tomer Y (2014) Thyroid antibodies: thyroid peroxidase and thyroglobulin antibodies. In: Shoenfeld Y, Meroni PL, Gershwin ME (eds) Autoantibodies, 3rd edn. Elsevier, Amsterdam, pp 365–373CrossRef

26.

Garber JR, Cobin RH, Gharib H, Hennessey JV, Klein I, Mechanick JI et al (2012) Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 18:988–1028CrossRefPubMed

27.

Tozzoli R, Bonaguri C, Melegari A, Antico A, Bassetti D, Bizzaro N (2013) Current state of diagnostic technologies in the autoimmunology laboratory. Clin Chem Lab Med 51:129–138CrossRefPubMed

28.

Bizzaro N, Tozzoli R, Villalta D (2014) Autoimmune diagnostics: the technology, the strategy and the clinical governance. Immunol Res 61:126–134CrossRef

29.

D’Aurizio F, Tozzoli R, Villalta D, Pesce G, Bagnasco M (2015) Immunoassay of thyroid peroxidase autoantibodies: diagnostic performance in automated third generation methods. A multicentre evaluation. Clin Chem Lab Med 53:415–421PubMed

30.

Tozzoli R, D’Aurizio F, Ferrari A, Castello R, Metus P, Caruso B et al (2016) The upper reference limit for thyroid peroxidase autoantibodies is method-dependent: a collaborative study with biomedical industries. Clin Chim Acta 452:61–65CrossRefPubMed

31.

D’Aurizio F, Metus P, Polizzi Anselmo A, Villalta D, Ferrari A, Castello R et al (2015) Establishment of the upper reference limit for thyroid peroxidase autoantibodies according to the guidelines proposed by the National Academy of clinical biochemistry: comparison of five different automated methods. Autoimmun Highlights 6:31–37CrossRef

32.

Baloch Z, Carayon P, Comte-Devolx B, Demers LM, Feldt-Rasmussen U, Henry JF et al (2003) Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 13:3–126CrossRefPubMed

33.

Godlewska M, Gora M, Buckle AM, Porebski BT, Kemp EH, Sutton BJ et al (2014) A redundant role of human thyroid peroxidase propeptide for cellular, enzymatic and immunological activity. Thyroid 24:371–382CrossRefPubMedPubMedCentral

34.

Nielsen CH, Brix TH, Gardas A, Banga JP, Hegedus L (2008) Epitope recognition patterns of thyroid peroxidase autoantibodies in healthy individuals and patients with Hashimoto’s thyroiditis. Clin Endocrinol (Oxf) 69:664–668CrossRef

35.

Vergani D, Mieli-Vergani G (2011) Cutting edge issues in autoimmune hepatitis. Clin Rev Allerg Immunol 42:309–321CrossRef

36.

Johnson PJ, McFarlane IG (1993) Meeting report: international autoimmune hepatitis group. Hepatology 18:998–1005CrossRefPubMed

37.

Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL et al (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929–938CrossRefPubMed

38.

Czaja AJ (2016) Diagnosis and management of autoimmune hepatitis: current status and future directions. Gut Liver 10:177–203CrossRefPubMedPubMedCentral

39.

Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL et al (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176CrossRefPubMed

40.

Czaja AJ (2008) Performance parameters of the diagnostic scoring systems for autoimmune hepatitis. Hepatology 48:1540–1548CrossRefPubMed

41.

Vergani D, Alvarez F, Bianchi FB, Conçado ELR, Mackay IR, Manns MP et al (2004) Liver autoimmune serology: a consensus statement from the committee for autoimmune serology of the International Autoimmune Hepatitis Group. J Hepatol 41:677–683CrossRefPubMed

42.

Villalta D, Bizzaro N, Da Re M, Tozzoli R, Komorowski L, Tonutti E (2008) Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders. Autoimmunity 41:105–110CrossRefPubMed

43.

Toh BH, Taylor R, Pollok V, Dearden S, Gill CC, Buchner C et al (2010) Actin-reactive discriminated from non-actin-reactive smooth muscle auto-antibody by immunofluorescence reactivity with rat epithelial cell line. Pathology 42:463–469CrossRefPubMed

44.

Villalta D, Girolami E, Alessio MG, Sorrentino MC, Tampoia M, Brusca I et al (2016) Autoantibody profiling in a cohort of pediatric and adult patients with autoimmune hepatitis. J Clin Lab Anal 30:41–46CrossRefPubMed

45.

Van der Windt DA, Jellema P, Mulder CJ, Kneepkens CM, van der Horst HE (2010) Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. J Am Med Assoc 303:1738–1746CrossRef

46.

Giersiepen K, Lelgemann M, Stuhldreher N, Ronfani L, Husby S, Koletzko S et al (2012) Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 54:229–241CrossRefPubMed

47.

Carroccio A, Vitale G, Di Prima L, Chifani N, Napoli S, La Russa C et al (2002) Comparison of anti-tranglutaminase ELISAs and anti-endomysial antibody assay in the diagnosis of celiac disease: a prospective study. Clin Chem 48:1546–1550PubMed

48.

Reeves GE, Squance ML, Duggan AE, Murugasu RR, Wilson RJ, Wong RC et al (2006) Diagnostic accuracy of coeliac serological tests: a prospective study. Eur J Gastroenterol Hepatol 18:493–451CrossRefPubMed

49.

Weiss B, Bujanover Y, Avidan B, Fradkin A, Weintraub I, Shainberg B (2004) Positive tissue transglutaminase antibodies with negative endomysial antibodies: low rate of celiac disease. Isr Med Assoc J 6:9–12PubMed

50.

Hill PG, Holmes GK (2008) Coeliac disease: a biopsy in not always necessary for diagnosis. Aliment Pharmacol Ther 27:572–577CrossRefPubMed

51.

Li M, Yu L, Tiberti C, Bonamico M, Taki I, Miao D et al (2009) A report on the international transglutaminase autoantibody workshop for celiac disease. Am J Gastroenterol 104:154–163CrossRefPubMedPubMedCentral

52.

Beltran L, Koening M, Egner W, Howard M, Butt A, Austin MR et al (2013) High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated. Clin Exp Immunol 176:190–198CrossRef

53.

Donaldson MR, Book LS, Leiferman KM, Zone JJ, Neuhausen SL (2008) Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease. J Clin Gastroenterol 42:256–260PubMed

54.

Alessio MG, Tonutti E, Brusca I, Radice A, Licini L, Sonzogni A et al (2012) Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease. J Pediatr Gastroenterol Nutr 55:44–49CrossRefPubMed

55.

Singh P, Kurray L, Agnihotri A, Das P, Verma AK, Sreenivas V et al (2015) Titers of anti-transglutaminase antibody correlate well with severity of villous abnormalities in celiac disease. J Clin Gastroenterol 49:212–217CrossRefPubMed

56.

Husby S, Koletzko S, Korponay-Szabó IR, Mearin ML, Phillips A, Shamir R et al (2012) European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of celiac disease. J Pediatr Gastroenterol Nutr 54:136–160CrossRefPubMed

57.

Egner W, Shrimpton A, Sargur R, Patel D, Swallow K (2012) ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonize assay performances across centres. J Pediatr Gastroenterol Nutr 55:733–735CrossRefPubMed

58.

Suh-Lailam BB, Davis KW, Tebo AE (2016) Immunoassays for the detection of IgA antibodies to tissue transglutaminase. Significance of multiples of upper limit of normal and inter-assay correlations. Clin Chem Lab Med 54:257–264CrossRefPubMed

59.

Rubio-Tapia A, Hill ID, Kelly CP, Calderwood AH, Murray JA (2013) ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol 108:656–676CrossRefPubMedPubMedCentral

60.

Bai JC, Fried M, Corazza GR, Schuppan D, Farthing M, Catassi C et al (2013) World gastroenterology organization global guidelines on celiac disease. J Clin Gastroenterol 47:121–126CrossRefPubMed

61.

Hill P, Austin A, Forsyth J, Holmes G (2015) British Society of Gastroenterology guidelines on the diagnosis and management of celiac disease. Gut 64:691–692CrossRefPubMed

62.

Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PH, Hadjivassiliou M et al (2012) Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med 10:13CrossRefPubMedPubMedCentral

63.

Catassi C, Elli L, Bonaz B, Bouma G, Carroccio A, Castillejo G et al (2015) Diagnosis of non-celiac gluten sensitivity (NCGS): the Salerno experts’ criteria. Nutrients 7:4966–4977CrossRefPubMedPubMedCentral

Titel: Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review
verfasst von: Renato Tozzoli
Danilo Villalta
Nicola Bizzaro
Publikationsdatum: 08.08.2016
Verlag: Springer US
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 1/2017
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-016-8579-y

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Challenges in the Standardization of Autoantibody Testing: a Comprehensive Review

Abstract

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2017

Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up

Anti-phospholipid Antibodies and Smoking: An Overview

Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome—A Retrospective Analysis and a Review of Additional Treatment in Pregnancy

Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review

A Critical Evaluation of Liver Pathology in Humans with Danon Disease and Experimental Correlates in a Rat Model of LAMP-2 Deficiency

Next-Generation Autoantibody Testing by Combination of Screening and Confirmation—the CytoBead® Technology

Neu im Fachgebiet HNO

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

HNO-Op. auch mit über 90?

Intrakapsuläre Tonsillektomie gewinnt an Boden

Bilateraler Hörsturz hat eine schlechte Prognose

Update HNO